---
title: "VK2735 in Chronic weight management: Prevalence"
description: "Formulary evidence on VK2735 in Chronic weight management: Prevalence. Topics: United States adults: measured prevalence of obesity, August 2021 to August 2023; United States adults: measured prevalence of severe obesity, August 2021 to August 2023; United States adults: trends in obesity and severe obesity, 2013 to 2023; United States adults: overweight, obesity, and severe obesity combined; 6 further topics. 10 evidence topics quoted from 8 sources."
canonical: "https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description/prevalence"
published: "2026-11-15T21:45:47-05:00"
modified: "2026-11-15T21:45:47-05:00"
---

# VK2735 in Chronic weight management: Prevalence

<a id="heading-2.2.1.2.2"></a>

## 2.2.1.2.2 Prevalence of Chronic weight management

<a id="topic-2.2.1.2.2-1"></a>

### United States adults: measured prevalence of obesity, August 2021 to August 2023

> “During August 2021–August 2023, the prevalence of obesity in adults was 40.3%, with no significant differences between men and women.”
> “The prevalence was 39.2% in men and 41.3% in women.”
> “The prevalence of obesity in adults ages 40–59 was 46.4%, which was higher than the prevalence in adults ages 20–39 (35.5%) and 60 and older (38.9%).”
> “The prevalence of obesity was lower in adults with a bachelor’s degree or more (31.6%) than in adults with less education”

Source: [Emmerich et al. (2024)](https://www.cdc.gov/nchs/products/databriefs/db508.htm)

<a id="topic-2.2.1.2.2-2"></a>

### United States adults: measured prevalence of severe obesity, August 2021 to August 2023

> “The prevalence of severe obesity in adults was 9.4% during August 2021–August 2023, and was higher in adults ages 20–39 (9.5%) and 40–59 (12.0%) than in adults age 60 and older (6.6%)”
> “The prevalence of severe obesity in men (6.7%) was lower than in women (12.1%) overall and for each age group.”

Source: [Emmerich et al. (2024)](https://www.cdc.gov/nchs/products/databriefs/db508.htm)

<a id="topic-2.2.1.2.2-3"></a>

### United States adults: trends in obesity and severe obesity, 2013 to 2023

> “From 2013–2014 through August 2021–August 2023, the age-adjusted prevalence of obesity in adults did not change significantly, while the age-adjusted prevalence of severe obesity increased from 7.7% to 9.7%”
> “In the United States, the prevalence of obesity in adults remains above the Healthy People 2030 goal of 36.0%”

Source: [Emmerich et al. (2024)](https://www.cdc.gov/nchs/products/databriefs/db508.htm)

<a id="topic-2.2.1.2.2-4"></a>

### United States adults: overweight, obesity, and severe obesity combined

> “In August 2021–August 2023, the age-adjusted prevalence of U.S. adults age 20 and older with obesity was 40.3%, including 9.7% with severe obesity and another 31.7% who were overweight.”
> “Unadjusted estimates were 40.3% for obesity, 9.4% for severe obesity, and 32.1% for overweight.”

Source: [Fryar et al. (2026)](https://www.cdc.gov/nchs/data/hestat/hestat111.htm)

<a id="topic-2.2.1.2.2-5"></a>

### United States states and territories: self-reported prevalence of obesity, 2025

> “These maps are based on self-reported weight and height from the Behavioral Risk Factor Surveillance System (BRFSS).”
> “In 2025, among U.S. states and territories with available data, all had an obesity prevalence higher than 25%, except the District of Columbia (24.2%).”
> “Overall, the Midwest (35.5%) and South (34.8%) had the highest prevalence of obesity, followed by the West (30.7%) and the Northeast (29.6%).”
> “21 states, Guam, and Puerto Rico had an obesity prevalence between 35% and less than 40%.”
> “No state or territory had an obesity prevalence of 40% or higher.”

Source: [CDC Adult Obesity Prevalence Maps (2026)](https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html)

<a id="topic-2.2.1.2.2-6"></a>

### United States adults: projected prevalence of obesity and severe obesity in 2030

> “The findings from our approach suggest with high predictive accuracy that by 2030 nearly 1 in 2 adults will have obesity (48.9%; 95% confidence interval [CI], 47.7 to 50.1), and the prevalence will be higher than 50% in 29 states and not below 35% in any state.”
> “Nearly 1 in 4 adults is projected to have severe obesity by 2030 (24.2%; 95% CI, 22.9 to 25.5), and the prevalence will be higher than 25% in 25 states.”

Source: [Ward et al. (2019)](https://pubmed.ncbi.nlm.nih.gov/31851800/)

<a id="topic-2.2.1.2.2-7"></a>

### United States adults: overweight and obesity in 2021 and forecast to 2050

> “In 2021, an estimated 15·1 million (95% UI 13·5–16·8) children and young adolescents (aged 5–14 years), 21·4 million (20·2–22·6) older adolescents (aged 15–24 years), and 172 million (169–174) adults (aged ≥25 years) had overweight or obesity in the USA.”
> “By 2050, the total number of children and adolescents with overweight and obesity will reach 43·1 million (37·2–47·4) and the total number of adults with overweight and obesity will reach 213 million (202–221).”
> “In 2050, in most states, a projected one in three adolescents (aged 15–24 years) and two in three adults (≥25 years) will have obesity.”

Source: [GBD 2021 US Obesity Forecasting Collaborators (2024)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11694015/)

<a id="topic-2.2.1.2.2-8"></a>

### Global adults: overweight and obesity in 2024

> “In 2024, 2.6 billion adults aged 18 years and older were overweight, including 940 million adults who were living with obesity”
> “Prevalence of overweight varied by region, from 32% in the WHO South-East Asia Region and the African Region to 68% in the Region of the Americas.”
> “About 16% of adults aged 18 years and older worldwide were living with obesity in 2024. The worldwide prevalence of obesity more than doubled between 1990 and 2024.”

Source: [WHO (2026)](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)

<a id="topic-2.2.1.2.2-9"></a>

### Global adults: overweight and obesity in 2021 and forecast to 2050

> “In 2021, an estimated 1·00 billion (95% uncertainty interval [UI] 0·989–1·01) adult males and 1·11 billion (1·10–1·12) adult females had overweight and obesity.”
> “China had the largest population of adults with overweight and obesity (402 million [397–407] individuals), followed by India (180 million [167–194]) and the USA (172 million [169–174]).”
> “Assuming the continuation of historical trends, by 2050, we forecast that the total number of adults living with overweight and obesity will reach 3·80 billion (95% UI 3·39–4·04), over half of the likely global adult population at that time.”

Source: [GBD 2021 Adult BMI Collaborators (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11920007/)

<a id="topic-2.2.1.2.2-10"></a>

### Global adults: number with obesity in 2022, pooled population-based data

> “The number of women and men with obesity in 2022 was 504 million (489–520) and 374 million (358–391), respectively, which was an increase of 377 million (360–393) and 307 million (290–324), respectively, from 1990.”
> “The countries with the largest absolute numbers of adults with obesity in 2022 were the USA, China, and India.”

Source: [NCD Risk Factor Collaboration (2024)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7615769/)

## Related pages
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management.md)
- [VK2735 in Chronic weight management: Terms and abbreviations](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations.md)
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary.md)
- [VK2735 in Chronic weight management: Product information and disease description](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description.md)
- [VK2735 in Chronic weight management: Clinical evidence](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence.md)
- [VK2735 in Chronic weight management: Economic information and modeling report](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics.md)
- [VK2735 in Chronic weight management: References](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references.md)
